- STAT+: Following dispute with FDA, UniQure is cleared to submit Huntington’s treatment for approvalThe FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker.STAT · 1mo ago↗ source
- Jazz turns to AbCellera for T cell engagers in up to $4.1B partnershipFor much of its first decade, Canadian antibody developer AbCellera signed partnership after partnership, securing 40 biopharma alliances that led to more than a dozen clinical-stage drug candidate…Endpoints · 1mo ago↗ source
- Update: Spot Bio launches with $40M to study non-viral gene therapy for muscular dystrophyA startup with operations in California and China has quietly begun tests of a genetic medicine that could restore dystrophin, the vital muscle protein that is broken or missing in people born with…